US2008248516A1PendingUtilityA1

Method for Using Division Arrested Cells in Screening Assays

56
Assignee: INVITROGEN CORPPriority: Sep 20, 2002Filed: Jun 12, 2008Published: Oct 9, 2008
Est. expirySep 20, 2022(expired)· nominal 20-yr term from priority
G01N 33/502G01N 33/5041G01N 33/6872C12Q 1/025G01N 33/5011G01N 33/5008
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Division arrested cells are used in screening assays to determine the effect of a substance of interest on the cells. The division arrested cells can be used in drug screening assays, signal transduction assays, and are especially useful in large scale, high throughput assays.

Claims

exact text as granted — not AI-modified
1 . A method for determining if a drug candidate has an effect on a mammalian cell, the method comprising:
 (a) contacting the mammalian cell with the drug candidate, and   (b) determining whether the drug candidate has an effect on the mammalian cell by measuring a change in the mammalian cell,   wherein either the meiotic or mitotic cycle of the mammalian cell has been stopped and cellular division can no longer take place.   
     
     
         2 . The method of  claim 1 , wherein activation of a G-protein coupled receptor is measured. 
     
     
         3 . The method of  claim 2 , wherein the G-protein coupled receptor is overexpressed by the mammalian cell. 
     
     
         4 . The method of  claim 2 , wherein the G-protein coupled receptor is selected from the group consisting of:
 (a) a serotonin receptor;   (b) a muscaranic acetylcholine receptor; and   (c) a β2 adrenergic receptor.   
     
     
         5 . The method of  claim 1 , wherein the change measured in the mammalian cell results from Ca 2+  mobilization. 
     
     
         6 . The method of  claim 1 , wherein the change measured in the mammalian cell is determined by measuring the activity of a reporter. 
     
     
         7 . The method of  claim 6 , wherein the reporter is selected from the group consisting of secreted alkaline phosphatase, luciferase, and green fluorescent protein. 
     
     
         8 . The method of  claim 1 , wherein the determination whether the drug candidate has an effect on the mammalian cell is made by comparison of the mammalian cell before and after the mammalian cell are contacted with the drug candidate. 
     
     
         9 . The method of  claim 1 , wherein the mammalian cell is a cell selected from the group consisting of:
 (a) a Chinese hamster ovary cell;   (b) a NIH3T3 cell;   (c) a HEK293 cell; and   (d) a M1WT3 cell.   
     
     
         10 . The method of  claim 1 , wherein the meiotic or mitotic cycle of the mammalian cell has been stopped by irradiation of the mammalian cell or exposure of the mammalian cell to mitomycin C.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.